Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.07
-0.00500-0.24%
At close: -
$2.10
0.031.45%
After Hours: Jun 6, 8:31 AM EDT
Comments
Loading...
MDxHealth Analyst Ratings and Price Targets | NASDAQ:MDXH | Benzinga
MDxHealth SA has a consensus price target of $9.2 based on the ratings of 6 analysts. The high is $18 issued by Oppenheimer on July 18, 2022. The low is $6 issued by Piper Sandler on November 7, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, Lake Street, and Piper Sandler on November 7, 2024, October 31, 2024, and March 7, 2024, respectively. With an average price target of $6.67 between Piper Sandler, Lake Street, and Piper Sandler, there's an implied 217.46% upside for MDxHealth SA from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Lake Street
BTIG
TD Cowen
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for MDxHealth
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/07/2024 | Buy Now | 185.71% | Piper Sandler | Jason Bednar52% | $8 → $6 | Maintains | Overweight | Get Alert |
| 10/31/2024 | Buy Now | 233.33% | Lake Street | — | → $7 | Initiates | → Buy | Get Alert |
| 03/07/2024 | Buy Now | 233.33% | Piper Sandler | Jason Bednar52% | $6 → $7 | Maintains | Overweight | Get Alert |
| 03/07/2024 | Buy Now | 280.95% | BTIG | Mark Massaro71% | $7 → $8 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | 185.71% | Piper Sandler | Jason Bednar52% | $10 → $6 | Maintains | Overweight | Get Alert |
| 05/31/2023 | Buy Now | 233.33% | TD Cowen | Dan Brennan62% | → $7 | Initiates | → Outperform | Get Alert |
| 05/16/2023 | Buy Now | 233.33% | BTIG | Mark Massaro71% | $8 → $7 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | 280.95% | BTIG | Mark Massaro71% | $8 → $8 | Maintains | Buy | Get Alert |
| 03/24/2023 | Buy Now | — | William Blair | Andrew Brackmann35% | — | Initiates | → Outperform | Get Alert |
| 03/09/2023 | Buy Now | 280.95% | BTIG | Mark Massaro71% | $12 → $8 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 376.19% | Piper Sandler | Jason Bednar52% | $15 → $10 | Maintains | Overweight | Get Alert |
| 11/09/2022 | Buy Now | 471.43% | BTIG | Mark Massaro71% | → $12 | Maintains | Buy | Get Alert |
| 10/31/2022 | Buy Now | 566.67% | BTIG | Mark Massaro71% | → $14 | Maintains | Buy | Get Alert |
| 08/26/2022 | Buy Now | 614.29% | BTIG | Mark Massaro71% | $13 → $15 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | 757.14% | Oppenheimer | Francois Brisebois40% | → $18 | Assumes | → Outperform | Get Alert |
FAQ
What is the target price for MDxHealth (MDXH) stock?
The latest price target for MDxHealth (NASDAQ:MDXH) was reported by Piper Sandler on November 7, 2024. The analyst firm set a price target for $6.00 expecting MDXH to rise to within 12 months (a possible 185.71% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MDxHealth (MDXH)?
The latest analyst rating for MDxHealth (NASDAQ:MDXH) was provided by Piper Sandler, and MDxHealth maintained their overweight rating.
When was the last upgrade for MDxHealth (MDXH)?
There is no last upgrade for MDxHealth
When was the last downgrade for MDxHealth (MDXH)?
There is no last downgrade for MDxHealth.
When is the next analyst rating going to be posted or updated for MDxHealth (MDXH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MDxHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MDxHealth was filed on November 7, 2024 so you should expect the next rating to be made available sometime around November 7, 2025.
Is the Analyst Rating MDxHealth (MDXH) correct?
While ratings are subjective and will change, the latest MDxHealth (MDXH) rating was a maintained with a price target of $8.00 to $6.00. The current price MDxHealth (MDXH) is trading at is $2.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
